Press Releases from DelveInsight Business Research LLP (4751 total)
Prosthetic Joint Infections Pipeline Therapeutics Assessment Report 2024 (Update …
DelveInsight's, "Prosthetic Joint Infections Pipeline Insight 2024" report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Prosthetic Joint Infections pipeline landscape. It…
Lamellar Icthyosis Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "Lamellar Icthyosis Pipeline Insight 2024" report provides comprehensive insights about 4+ companies and 5+ pipeline drugs in Lamellar Icthyosis pipeline landscape. It covers the…
Influenza Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "Influenza Pipeline Insight 2024" report provides comprehensive insights about 120+ companies and 120+ pipeline drugs in Influenza pipeline landscape. It covers the Influenza pipeline…
Gastrointestinal Stromal Tumor Pipeline Therapeutics Assessment Report 2024 (Upd …
DelveInsight's, "Gastrointestinal Stromal Tumors Pipeline Insight 2024" report provides comprehensive insights about 25+ companies and 28+ pipeline drugs in Gastrointestinal Stromal Tumors (GIST) pipeline landscape.…
Lipodystrophy Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "Lipodystrophy Pipeline Insight 2024" report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Lipodystrophy pipeline landscape. It covers the pipeline drug…
Malignant Pleural Effusion Pipeline Therapeutics Assessment Report 2024 (Updated …
DelveInsight's, "Malignant Pleural Effusion Pipeline Insight 2024" report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in Malignant Pleural Effusion pipeline landscape. It…
Axial Spondyloarthritis Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "Axial Spondyloarthritis Pipeline Insight 2024" report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Axial Spondyloarthritis pipeline landscape. It covers the…
Blastic Plasmacytoid Dendritic Neoplasm Pipeline Therapeutics Assessment Report …
DelveInsight's, "Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Malignancy Pipeline Insight 2024" report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in Blastic Plasmacytoid…
Bronchiectasis Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "Bronchiectasis Pipeline Insight 2024" report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Bronchiectasis pipeline landscape. It covers the pipeline drug…
Scars Clinical Trials | A Drug Pipeline Analysis Report 2024 | First String Rese …
United States, Nevada, Las Vegas, DelveInsight's 'Scars Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Scars therapies in various stages…
Schizophrenia Clinical Trials | A Drug Pipeline Analysis Report 2024 | Otsuka Ph …
DelveInsight's 'Schizophrenia Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Schizophrenia therapies in various stages of clinical development, major pharmaceutical…
Sciatica Clinical Trials | A Drug Pipeline Analysis Report 2024 | Sciatica Clini …
United States, Nevada, Las Vegas, DelveInsight's 'Sciatica Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Sciatica therapies in various stages…
Sepsis Clinical Trials | A Drug Pipeline Analysis Report 2024 | SciClone Pharmac …
DelveInsight's 'Sepsis Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Sepsis therapies in various stages of clinical development, major pharmaceutical…
Seborrhoeic Dermatitis Clinical Trials | A Drug Pipeline Analysis Report 2024 | …
DelveInsight's 'Seborrhoeic Dermatitis Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Seborrhoeic Dermatitis therapies in various stages of clinical development,…
Secondary Progressive Multiple Sclerosis Clinical Trials | A Drug Pipeline Analy …
DelveInsight's 'Secondary Progressive Multiple Sclerosis Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Secondary Progressive Multiple Sclerosis therapies in various…
Sensorineural Hearing Loss Clinical Trials | A Drug Pipeline Analysis Report 202 …
DelveInsight's 'Sensorineural Hearing Loss Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Sensorineural Hearing Loss therapies in various stages of…
Raynaud's Disease Clinical Trials, Key Companies, Emerging Therapies | A Drug Pi …
DelveInsight's 'Raynaud's Disease Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Raynaud's Disease therapies in various stages of clinical development,…
Ulcerative Colitis Clinical Trials | A Drug Pipeline Analysis Report 2024 | Oppi …
DelveInsight's 'Ulcerative Colitis Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Ulcerative Colitis therapies in various stages of clinical development,…
Acute Kidney Injury Clinical Trials | A Drug Pipeline Analysis Report 2024 | GUA …
DelveInsight's 'Acute Kidney Injury Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Acute Kidney Injury therapies in various stages of…
Burns Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "Burns Pipeline Insight 2024" report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in Burns pipeline landscape. It covers the pipeline drug…
Cancer Cachexia Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "Cancer Cachexia Pipeline Insight 2024" report provides comprehensive insights about 12+ companies and 15+ pipeline drugs in Cancer Cachexia pipeline landscape. It covers the…
Dementia with Diabetes Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "Dementia with Diabetes Pipeline Insight 2024" report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Dementia with Diabetes pipeline landscape. It…
Granulomatosis with Polyangiitis Pipeline Therapeutics Assessment Report 2024 (U …
DelveInsight's, "Granulomatosis with Polyangiitis Pipeline Insight 2024" report provides comprehensive insights about 2+ companies and 2+ pipeline drugs in Granulomatosis with Polyangiitis pipeline landscape. It…
Graves Ophthalmopathy Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "Graves Ophthalmopathy Pipeline Insight 2024" report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Graves Ophthalmopathy pipeline landscape. It covers the…
Graft Versus Host Disease Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "Graft versus host disease Pipeline Insight 2024" report provides comprehensive insights about 60+ GvHD companies and 65+ pipeline drugs in Graft versus host disease…
Glioma Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "Glioma Pipeline Insight 2024" report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in the Glioma pipeline landscape. It covers the Glioma…
Dry Age-related Macular Degeneration Pipeline Therapeutics Assessment Report 202 …
DelveInsight's, "Dry Age-related Macular Degeneration Pipeline Insight 2024" report provides comprehensive insights about 70+ companies and 80+ pipeline drugs in Dry Age-related Macular Degeneration…
Diabetic Peripheral Neuropathy Pipeline Therapeutics Assessment Report 2024 (Upd …
DelveInsight's, "Diabetic Peripheral Neuropathy Pipeline Insight 2024" report provides comprehensive insights about 10+ companies and 15+ pipeline drugs in Diabetic Peripheral Neuropathy pipeline landscape. It…
Angelman Syndrome Treatment Market Size is expected to grow by 2034, estimates D …
Angelman Syndrome Treatment Market is projected to witness substantial growth over the next few years, driven by advancements in treatment modalities and increasing awareness of…
Peripheral Arterial Disease Pipeline Therapeutics Assessment Report 2024 (Update …
DelveInsight's, "Peripheral Arterial Disease Pipeline Insight 2024" report provides comprehensive insights about 18+ companies and 20+ pipeline drugs in Peripheral Arterial Disease pipeline landscape. It…
Epilepsy Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "Epilepsy Pipeline Insight 2024" report provides comprehensive insights about 85+ companies and 90+ pipeline drugs in Epilepsy pipeline landscape. It covers the pipeline drug…
Diffuse Large B-cell Lymphoma Pipeline Therapeutics Assessment Report 2024 (Upda …
DelveInsight's, "Diffuse Large B-Cell Lymphoma Pipeline Insight 2024" report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in Diffuse Large B-Cell Lymphoma pipeline…
Chronic Obstructive Pulmonary Disease Pipeline Therapeutics Assessment Report 20 …
(Albany, United States) As per DelveInsight's assessment, globally, the Chronic Obstructive Pulmonary Disease pipeline constitutes 65+ key companies continuously working towards developing 70+ Chronic Obstructive…
Biliary Tract Cancer Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "Biliary Tract Cancers Pipeline Insight 2024" report provides comprehensive insights about 80+ companies and 80+ pipeline drugs in the Biliary Tract Cancers Pipeline landscape.…
X-linked Adrenoleukodystrophy Pipeline Therapeutics Assessment Report 2024 (Upda …
DelveInsight's, "X-Linked Adrenoleukodystrophy Pipeline Insight, 2024," report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in X-Linked Adrenoleukodystrophy (X-ALD) pipeline landscape. It covers…
Polymyositis Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "Polymyositis Pipeline Insight 2024" report provides comprehensive insights about 7+ companies and 7+ pipeline drugs in Polymyositis pipeline landscape. It covers the pipeline drug…
Alcohol Use Disorder Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "Alcohol Use Disorder Pipeline Insight, 2024" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Alcohol Use Disorder pipeline landscape. It…
Obesity Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "Obesity Pipeline Insight 2024" report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in Obesity pipeline landscape. It covers the pipeline drug…
Hairy Cell Leukemia Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "Hairy Cell Leukemia Pipeline Insight 2024" report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Hairy Cell Leukemia pipeline landscape. It…
Acute Kidney Injury Market Size in the 7MM was ~USD 6,230 million in 2022, estim …
DelveInsight's "Acute Kidney Injury Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of the Acute Kidney Injury, historical and forecasted…
Acute Respiratory Distress Syndrome Pipeline Therapeutics Assessment Report 2024 …
DelveInsight's, "Acute Respiratory Distress Syndrome Pipeline Insight 2024" report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Acute Respiratory Distress Syndrome pipeline…
Amyotrophic Lateral Sclerosis Pipeline Therapeutics Assessment Report 2024 (Upda …
DelveInsight's, "Amyotrophic Lateral Sclerosis Pipeline Insight 2024" report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Amyotrophic Lateral Sclerosis pipeline landscape. It…
Chronic Spontaneous Urticaria Pipeline Therapeutics Assessment Report 2024 (Upda …
DelveInsight's, "Chronic Spontaneous Urticaria Pipeline Insight, 2024," report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Chronic Spontaneous Urticaria pipeline landscape. It…
Cluster Headache Syndrome Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "Cluster Headache Syndrome Pipeline Insight 2024" report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Cluster Headache Syndrome pipeline landscape. It…
ER+ HER2-VE Breast Cancer Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "ER positive, HER2 negative Breast Cancer Pipeline Insight, 2024" report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in ER positive, HER2…
Fanconi Anemia Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "Fanconi Anemia Pipeline Insight 2024" report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Fanconi Anemia pipeline landscape. It covers the…
Diabetic Kidney Disease Clinical Trials | A Drug Pipeline Analysis Report 2024 | …
United States, Nevada, Las Vegas, DelveInsight's 'Diabetic Kidney Disease Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Diabetic Kidney Disease…
Diabetic Macular Edema Clinical Trials | A Drug Pipeline Analysis Report 2024 | …
DelveInsight's 'Diabetic Macular Edema Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Diabetic Macular Edema therapies in various stages of…
Diabetic Nephropathy Clinical Trials | A Drug Pipeline Analysis Report 2024 | Ba …
United States, Nevada, Las Vegas, DelveInsight's 'Diabetic Nephropathy Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Diabetic Nephropathy therapies in…
Sickle Cell Disease Clinical Trials | A Drug Pipeline Analysis Report 2024 | Bel …
DelveInsight's 'Sickle Cell Disease Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Sickle Cell Disease therapies in various stages of…
